(Q34991834)

5 August 2017

1 reference

title

Ex vivo expansion of hematopoietic stem cells by cytokines (English)

1 reference

5 August 2017

Toshio Heike

1

1 reference

5 August 2017

Tatsutoshi Nakahata

series ordinal

2

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Biochimica et Biophysica Acta

5 August 2017

published in

1 reference

5 August 2017

volume

1592

1 reference

5 August 2017

issue

3

1 reference

5 August 2017

page(s)

313-321

1 reference

Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

SCID mouse models of human stem cell engraftment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Development of human lymphocyte-engrafted SCID mice as a model for immunotoxicity assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

RAG-1-deficient mice have no mature B and T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

A severe combined immunodeficiency mutation in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Humoral regulation of hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

A bioactive designer cytokine for human hematopoietic progenitor cell expansion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

gp130-stimulating designer cytokine Hyper-interleukin-6 synergizes with murine stroma for long-term survival of primitive human hematopoietic progenitor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Assay systems for hematopoietic stem and progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

A newly discovered class of human hematopoietic cells with SCID-repopulating activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Ex vivo manipulation of hematopoietic stem and progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Ex vivo expansion of transplantable human hematopoietic stem cells: where do we stand in the year 2000?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Direct contact between CD34+lin- cells and stroma induces a soluble activity that specifically increases primitive hematopoietic cell production

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

Ex vivo expansion of hematopoietic progenitor cells and mature cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2802%2900324-5

7 January 2021

10.1016/S0167-4889(02)00324-5

Identifiers

DOI

1 reference

5 August 2017

1 reference